Aileron Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-The University of Texas/Texas A&M Investment Management Company(6.2%),The Board of Regents of the University of Texas System(6.2%)
Aileron Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-The University of Texas/Texas A&M Investment Management Company(6.2%),The Board of Regents of the University of Texas System(6.2%)
Aileron Therapeutics | SC 13G：超過5%持股股東披露文件-The University of Texas/Texas A&M Investment Management Company(6.2%),The Board of Regents of the University of Texas System(6.2%)
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。